HOSPITAL MANAGEMENT AND AMBULATORY PATIENT CARE AFTER COVID-19 INFECTION IN KIDNEY TRANSPLANT

ABSTRACT INTRODUCTION A large number de registries have been collected both kidney transplant recipients infected with COVID-19. MATERIALS AND METHODS From March 2020 to April 2021, our team conducted an observational study, which included all patients that show a positive polymerase chain reaction to COVID-19. Patients were divided into two groups: ambulatory patient care and patient who need hospital admissions. RESULTS A total de 76 kidney transplants infected with COVID-19, 33% required hospital admission and 65% received ambulatory treatment. 28% of our patients were asymptomatic and 6,8% died. Immunosuppressive treatment was modified in both study groups, there were not any acute rejection episodes or changes in the HLA antibodies profile in our patients during our clinical trial. DISCUSSION In our study there was a significant percentage of patients who did not require hospital admission compared to other studies. In addition, we think that the reduction of immunosuppression can be a safe and reliable treatment.